Back to Journals » OncoTargets and Therapy » Volume 9

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Total article views   Abstract views HTML views PDF downloads Totals
4,964 Dovepress* 3,669 646+ 1,001 4,315
PubMed Central* 0 649 270 649
Totals 3,669 1,295 1,271 4,964
*Since 15 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar